03:32 AM EST, 11/29/2024 (MT Newswires) -- Nikhil Lalwani, Director, President & Chief Executive Officer, on November 26, 2024, sold 33,481 shares in Ani Pharmaceuticals ( ANIP ) for $1,941,442. Following the Form 4 filing with the SEC, Lalwani has control over a total of 370,378 shares of the company, with 370,378 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1023024/000182262924000014/xslF345X05/wk-form4_1732747122.xml